Researchers say they may have found a way to bring a cure for HIV a step closer by deploying the mRNA technology used in ...

Meghan McCain, a former co-host of “The View,” is facing pushback from social media after she promoted a partnership with a ...

A new multinational study analyzing data from over 230 million people across 20 global sites highlights the relationship ...

Researchers at the Peter Doherty Institute for Infection and Immunity in Melbourne have achieved a significant breakthrough ...

Researchers from UConn's College of Agriculture, Health and Natural Resources (CAHNR) and College of Liberal Arts and ...

Meghan McCain announced on Wednesday that she had partnered with a "detox" product for people who "regret taking" the ...

The US Department of Health and Human Services will not extend a grant funding the Center for HIV/AIDS Vaccine Development, ...

TriLink BioTechnologies®, a division of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI ), announced a non-exclusive ...

Alnylam Pharmaceuticals Inc. won’t get another chance at its patent infringement suit against Moderna Inc. over its mRNA Covid-19 vaccine, a federal appeals court ruled Wednesday.

Downstream processing for mRNA manufacturing is currently too complex, but simplifying by using precipitation looks promising.

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

In this week’s edition of InnovationRx, we look at the impact of Trump’s proposed budget cuts on biomedical research and ...